Calidi Biotherapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Calidi Biotherapeutics, Inc. reported Earnings Per Share Diluted of $5.95 (loss) per share for the year ending 2025.

  • Calidi Biotherapeutics, Inc. showed an increase of +83.3% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Calidi Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Calidi Biotherapeutics, Inc.'s Earnings Per Share Diluted has declined by 299.0%.
  • Historical annual values: Fiscal year 2025: $5.95 (loss) per share | Fiscal year 2024: $35.70 (loss) per share | Fiscal year 2023: $17.33 (loss) per share | Fiscal year 2022: $2.99 per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: